Traws Pharma, Inc. — Director's Dealing 2013

Dec 24, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-12-20

Reporting Person: MCKEARN THOMAS J (President, R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-20	Stock Option (right to purchase)	$13.48	A	72000	Acquired	2023-12-20	Common Stock (72000)	Direct

Footnotes

F1: These options vest over 4 years in 48 monthly installments.